MedRx Co., Ltd
JPX: 4586.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yonehiro Matsumura
- Employees
- 22
- Headquarters
- Higashikagawa, Japan
- IPO year
- 2013
- Market cap
- ¥4.7B
- Website
- https://www.medrx.co.jp
Loading 4586…
Loading profile data…Frequently asked questions about 4586
What does MedRx Co., Ltd (4586.T) do?
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops medicines based on Ionic liquid transdermal system (ILTS) and Nano-sized Colloid Transdermal System (NCTS); and researches and develops painless transdermal administration syste...
Where does 4586.T trade?
MedRx Co., Ltd (4586.T) trades on the Tokyo Stock Exchange.
What sector is 4586.T in?
MedRx Co., Ltd (4586.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of MedRx Co., Ltd?
Yonehiro Matsumura is the chief executive officer of MedRx Co., Ltd (4586.T).
Where is MedRx Co., Ltd headquartered?
MedRx Co., Ltd is headquartered in Japan.
Does 4586.T pay a dividend?
MedRx Co., Ltd (4586.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4586.T go public?
MedRx Co., Ltd (4586.T) completed its initial public offering in 2013.